H16.32
Diffuse interstitial keratitis
Clinical Classification Guidelines
Inclusion Terms
- Cogan's syndrome
Medical Intelligence & Overview
Diffuse interstitial keratitis is a rare eye condition characterized by inflammation of the corneal stroma, the middle layer of the cornea. This inflammation affects the entire cornea and can lead to visual impairment if not managed properly. Often associated with autoimmune or inflammatory diseases, this condition can be part of broader syndromes such as Cogan's syndrome, which involves inflammation of the eye and inner ear.
Causes & Symptoms
Clinical Causes: Autoimmune disorders, such as Cogan’s syndrome Infections, including syphilis, herpes simplex virus, and others Idiopathic factors (unknown causes) Associated systemic inflammatory conditions Previous ocular trauma or surgeries
Key Symptoms: Blurred or decreased vision in the affected eye Eye redness and swelling Eye pain or discomfort Photophobia (sensitivity to light) Tearing or watery eyes Presence of corneal haze or opacities upon examination Possible sensation of a foreign body in the eye
Diagnostic & Treatment
Diagnosis Path: Serological tests to identify underlying infections or autoimmune markers Corneal sensitivity tests Imaging studies such as anterior segment optical coherence tomography (OCT) Assessment for systemic diseases associated with the condition
Treatment Protocols: Topical corticosteroids to decrease corneal inflammation Cycloplegic eye drops to relieve pain and prevent further spasm of the iris muscles Systemic medications if an underlying autoimmune or infectious process is identified Antibiotics or antivirals if an infection is present Immunosuppressive therapy for autoimmune-related cases Regular monitoring to assess response and prevent complications such as corneal scarring or neovascularization
Clinical Advice & FAQs
Billing Guidance
Is H16.32 a billable ICD-10 code?
Yes, H16.32 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H16.32?
Clinical documentation must specify the nature of Diffuse interstitial keratitis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference